Fungicidal effect and oral acute toxicity of Cassia spectabilis leaf extract

Japanese Journal of Medical Mycology

Volumn 49, Issue 4, 2008, Pages 299-304

  Sangetha, S ^a   Zuraini, Z ^a   Sasidharan, S ^b   Suryani, S ^a  

^a SCHOOL OF PHYSICS   (Malaysia)

^b AIMST UNIVERSITY   (Malaysia)

Author keywords

Candida albicans; Cassia spectabilis leaf; Fungicidal activity; Scanning electron microscopy; Toxicity

Indexed keywords

CASSIA SPECTABILIS EXTRACT; MICONAZOLE NITRATE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; AUTOPSY; BODY WEIGHT; BROTH DILUTION; CANDIDA ALBICANS; CANDIDIASIS; CASSIA SPECTABILIS; CELL KILLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISK DIFFUSION; DRUG BLOOD LEVEL; DRUG FATALITY; FEMALE; FUNGICIDAL ACTIVITY; FUNGUS GROWTH; GROWTH INHIBITION; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY MASS; LETHAL DOSE; LIVER WEIGHT; LUNG WEIGHT; MALE; MEDICINAL PLANT; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; OPTICAL DENSITY; PLANT LEAF; SCANNING ELECTRON MICROSCOPY; SPLEEN WEIGHT; TREATMENT DURATION; ULTRASTRUCTURE; WEIGHT GAIN; YEAST CELL;

ADMINISTRATION, ORAL; ANIMALS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CASSIA; MICE; PLANT COMPONENTS; PLANT EXTRACTS;

ANIMALIA; CANDIDA; CANDIDA ALBICANS; MUS; SENNA SPECTABILIS;

EID: 56549095282     PISSN: 09164804     EISSN: None     Source Type: Journal    
DOI: 10.3314/jjmm.49.299     Document Type: Article

References (13)

1. Cosa P, Vlietinck AJ, Berghe DV, Maes L: Anti-infective potential of natural products: How to develop a stronger in vitro 'proof-of-concept'. J Ethnopharmacol 106: 290-302, 2006.
2. Chopra I, Hodgson J, Metcalf B, Poste G: New approaches to the control of infections caused by antibiotic resistant bacteria. An industry perspective. JAMA 275: 401-403, 1996.
3. Baquero F: Gram-positive resistance: Challenges for the development of new antibiotics. J Antimicrob Chemoth 39: 1-6, 1997.
4. Viegas JRC, Bolzani VS, Furlan M, Barreiro eJ, Young MCM, Tomazela DM, Eberlin MN: Further bioactive Piperidine alkaloids from the flowers and green fruits of Cassia spectabilis. J Nat Prod 67: 908-910, 2004.
5. Lorenzi H, Matos FJA: Plantas Medicinais do Brasil Nativas e Exóicas, pp.291, Instituto Plantarum, Nova Odessa, 2002.
6. rd ed. Approved standard. NCCLS document M100-S12. Wayne PA., 2002.
7. Borgers M, Van De Ven MA, Van Cutsen J: Structural degeneration of Aspergillus fumigatus after exposure to saperconazole. J Med Vet Mycol 27: 381-389. 1989.
8. Yoga Latha L, Sasidharan S, Zuraini Z, Suryani S, Shirley L, Sangetha S: Antibacterial activity and toxicity of Psophocarpus tetragonolobus. Pharm Biol 45: 31-36. 2007.
9. Anaissie E, Hachem R, K-Tin-U C, Stephens LC, Bodey GP: Experimental hematogenous candidiasis caused by Candida krusei and Candida albicans: species differences in pathogenicity. Infect Immun 61: 1268-1271, 1993.
10. OECD, Organization for Economic Cooperation and Development: Guidelines for the Testing of Chemicals: Revised Draft Guideline. Acute Oral Toxicity, pp. 423, 2000.
11. Bagg J, Sweeney MP, Lewis MA, Jackson MS, Coleman D, Baxter W, McEndrick S, McHugh S: High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer. Palliat Med 17: 477-481, 2003.
12. Jarvis WR: Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 20: 1526-1530, 1995.
13. Eggimann P, Garbino J, Pittet D: Management of Candida species infections in critically ill patients. Lancet Infect Dis 3: 772-785, 2003.